J&J Highlights Spravato Remission Rates in Push for Depression Market Expansion
Johnson & Johnson unveiled a new promotional poster at the American Psychiatric Association meeting in Chicago on Tuesday, centering on Spravato’s remission sta
Johnson & Johnson unveiled a new promotional poster at the American Psychiatric Association meeting in Chicago on Tuesday, centering on Spravato’s remission sta
Malcolm Brenner, a globally recognized physician‑scientist, has been named director of the newly created Houston Methodist Center for Cell and Gene Therapy. The
Researchers at the Association for Psychological Science conducted a study that challenges the assumption that emotionally charged words grab our attention. The
The latest commentary on personal finance highlights a growing backlash against hustle culture’s relentless push to accumulate wealth at any cost. Writers and p
Researchers at Sanford Burnham Prebys have made a breakthrough in understanding how proteins fold into specific shapes, a process crucial for their biological f
Up to 80% of people receiving chemotherapy experience „chemo brain,„a condition that impairs cognitive function. Researchers have found a simple solution. A stu
Eli Lilly, Novo Nordisk, AstraZeneca and several other firms presented fresh GLP‑1 clinical and preclinical data at the American Diabetes Association’s national
Researchers at the University of Zurich discovered biomarkers of sleep loss in saliva on June 12. A single saliva sample can detect acute sleep deprivation. Thi
Researchers at the University of Oulu and Oulu University Hospital studied 264 mother-infant pairs between 2023 and 2024. The study followed newborns and their
A team of neuroscientists and geneticists has identified a set of liver‑based genes that appear to control the most severe forms of cocaine addiction. The resea
Researchers in Japan studied 2,044 older adults, finding a link between low vitamin C levels and reduced brain connectivity. The study was conducted by Haruka N
Researchers have found a new, effective treatment for post-traumatic stress disorder. The therapy is brief and can be scaled up. It was reported in a recent stu